Literature DB >> 1064790

Spironolactone-associated aggravation of renal functional impairment.

T J Neale, K L Lynn, R R Bailey.   

Abstract

Five patients in whom deterioration in renal function was associated with the use of the aldosterone antagonist, spironolactone, are reported. Care in the use of this drug is urged, especially in the elderly. Patients with known renal functional impairment should not receive this agent.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1064790

Source DB:  PubMed          Journal:  N Z Med J        ISSN： 0028-8446


  6 in total

1.  The kidney and antihypertensive therapy.

Authors:  R R Bailey
Journal:  Drugs       Date:  1976       Impact factor: 9.546

2.  Postmarketing surveillance of enalapril. II: Investigation of the potential role of enalapril in deaths with renal failure.

Authors:  C J Speirs; C T Dollery; W H Inman; N S Rawson; L V Wilton
Journal:  BMJ       Date:  1988-10-01

3.  Moduretic-induced metabolic acidosis and hyperkalaemia.

Authors:  H H Wan; M D Lye
Journal:  Postgrad Med J       Date:  1980-05       Impact factor: 2.401

4.  Limitation on the use of amiloride in early renal failure.

Authors:  H Knauf; K Reuter; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

5.  Effects of spironolactone on serum and muscle electrolytes in patients on long-term diuretic therapy for congestive heart failure and/or arterial hypertension.

Authors:  T Dyckner; P O Wester; L Widman
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 6.  Diuretics and potassium in the elderly.

Authors:  D W Levy; M Lye
Journal:  J R Coll Physicians Lond       Date:  1987-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.